Draft guidance on management of rolling reviews for drug submissions: Performance targets and standards, cancellation (English, HTML)

View metadata and access the original English HTML file: Draft guidance on management of rolling reviews for drug submissions: Performance targets and standards, cancellation.

Format

HTML

Access

file-only

Publisher-reported update

2023-09-01

The time to complete the screening of a drug submission with a rolling review is 25 days. Once the screening acceptance letter is issued, the review 1 period would begin. The submission would immediately be placed on “rolling review” until Health Canada receives all of the missing information, as indicated in the notice.

Access original file